Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR17 Emtricitabine and tenofovir alafenamide
D10835 Emtricitabine and tenofovir alafenamide <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Combinations
Emtricitabine/ Tenofovir Alafenamide Fumarate
D10835 Emtricitabine and tenofovir alafenamide
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D10835 Emtricitabine and tenofovir alafenamide
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D10835 Emtricitabine and tenofovir alafenamide
DG03107 Anti-HIV agent
D10835 Emtricitabine and tenofovir alafenamide
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
D10835 Emtricitabine and tenofovir alafenamide
Transporter substrate
DG01665 ABCB1 substrate
D10835 Emtricitabine and tenofovir alafenamide
DG03001 CTSA substrate
D10835 Emtricitabine and tenofovir alafenamide
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D10835 Emtricitabine and tenofovir alafenamide
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D10835 Emtricitabine and tenofovir alafenamide <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10835
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10835
Drug transporters
D10835
